Botulinum toxin A topical - Allergan

Drug Profile

Botulinum toxin A topical - Allergan

Alternative Names: ANT 1207

Latest Information Update: 07 Feb 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Anterios
  • Developer Allergan
  • Class Antimigraines; Antispasmodics; Bacterial proteins; Bacterial toxins; Botulinum toxins; Muscle relaxants; Urologics
  • Mechanism of Action Acetylcholine inhibitors; Glutamate-antagonists; Neuromuscular blocking agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Acne vulgaris; Facial-wrinkles; Hyperhidrosis

Most Recent Events

  • 07 Feb 2018 Discontinued - Phase-II for Hyperhidrosis, Facial wrinkles and Acne vulgaris in USA (Topical) (not listed on Allergan pipeline, February 2018)
  • 01 Feb 2016 Anterios completes a phase II trial in Hyperhidrosis in USA (NCT02479139)
  • 07 Jan 2016 Anterios has been acquired by Allergan
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top